Cartesian Therapeutics
RNAC
#8958
Rank
โ‚น17.35 B
Marketcap
โ‚น568.93
Share price
4.24%
Change (1 day)
-12.29%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): -โ‚น170.76

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น172.35. In 2021 the company made an earnings per share (EPS) of -โ‚น667.15 an increase over its 2020 EPS that were of -โ‚น1,918.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น170.76
2021-โ‚น667.15-65.22%
2020-โ‚น1,918-43.44%
2019-โ‚น3,391-58.08%
2018-โ‚น8,089-9.35%
2017-โ‚น8,923-29.16%
2016-โ‚น12,596